Fact CheckerSign in

NCT02375841Active, not recruiting

Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers

Source: ClinicalTrials.gov · Last updated 18 Mar 2026

Brief summary (registry, in English)

The purpose of this study is to learn more about the way physicians communicate with brain tumor patients. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. Ultimately, the investigators hope to use these findings to improve communication between patients, caregivers and their doctors.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
309 (actual)
First submitted
18 Feb 2015
Start date
Feb 2015
Primary completion date
Feb 2027
Lead sponsor
Memorial Sloan Kettering Cancer Center
Diseases
Glioblastoma
NCT number
NCT02375841

What you commit to

  • Study type: Observational
  • Participants enrolled: 309
  • From Feb 2015 to the primary completion date, Feb 2027
  • 8 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient Exclusion Criteria:
  • A patient will be excluded if in the opinion of his/her attending neuro-oncologist or the covering neuro-oncologist, he does not have the capacity to consent to the study based on clinical evaluation
  • Aphasia precluding comprehension and verbalization of consent to participate, in the estimation of the attending physician.
    • Caregiver Exclusion Criteria:
  • There are no caregiver exclusion criteria.

Who the study is looking for

  • Patient Inclusion Criteria:
  • 18 years or older
  • Pathologic diagnosis of WHO grade IV glioma, as per MSKCC medical record or outside medical record.
  • In the judgment of the consenting professional, proficiency in English that will allow the participant to be able to complete study questionnaires and assessments. Many of the study assessments are available only in English.
  • At the time of consent, orientation to self, place, month and year
    • Caregiver Inclusion Criteria:
  • 18 years or older
  • Identified by the patient as a relative, friend, or partner with whom he or she has a significant relationship and who provides him or her informal (unpaid) care (i.e., physical or emotional assistance).
  • In the judgment of the consenting professional, proficiency in English that will allow to complete study questionnaires and assessments. Many of the study assessments are available only in English.
    • Oncologist Inclusion Criteria:
  • Treating Neuro-Oncologist in the Department of Neurology

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Memorial Sloan Kettering Basking Ridge
Coordinator of this site? Confirm its status
Basking RidgeUnited StatesUnknown status
University of Vermont Medical Center
Coordinator of this site? Confirm its status
BurlingtonUnited StatesUnknown status
Memorial Sloan Kettering Commack
Coordinator of this site? Confirm its status
CommackUnited StatesUnknown status
Henry Ford Hospital
Coordinator of this site? Confirm its status
DetroitUnited StatesUnknown status
Memorial Sloan Kettering Westchester
Coordinator of this site? Confirm its status
HarrisonUnited StatesUnknown status
Memorial Sloan Kettering Monmouth
Coordinator of this site? Confirm its status
MiddletownUnited StatesUnknown status
Memorial Sloan Kettering Bergen
Coordinator of this site? Confirm its status
MontvaleUnited StatesUnknown status
Memorial Sloan-Kettering Cancer Center
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.